Evidence map›Paper›PMID 39184858›Full record

ArticleFrontiers in pediatrics2024

Megeshinee Naidoo, Kimesh L Naidoo, Carl Lombard, Alicia C Desmond, Richard Clark, James F Rooney, Glenda Gray, Dhayendre Moodley

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Megeshinee NaidooCentre for the Program of AIDS Research in South Africa (CAPRISA), Durban, South Africa.
Kimesh L NaidooDepartment of Paediatrics and Child Health, School of Clinical Medicine, University of KwaZulu Natal, Durban, South Africa.
Carl LombardBiostatistics Unit, South African Medical Research Council, Tygerberg, South Africa.
Alicia C DesmondCentre for the Program of AIDS Research in South Africa (CAPRISA), Durban, South Africa.
Richard ClarkGilead Sciences Inc, Foster City, CA, United States.
James F RooneyGilead Sciences Inc, Foster City, CA, United States.
Glenda GraySouth African Medical Research Council, Cape Town, South Africa.
Dhayendre MoodleyCentre for the Program of AIDS Research in South Africa (CAPRISA), Durban, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: We evaluated growth metrics in HIV unexposed African breastfed infants in the first 18 months of life in association with Design: We conducted a secondary data analysis of a TDF-PrEP randomized control trial (CAP016 RCT). Pregnant women without HIV were randomized to initiating TDF-PrEP in pregnancy (Immediate-PrEP-IP) or deferred initiation of TDF-PrEP at cessation of breastfeeding (Deferred-PrEP-DP). Methods: Infant weight (W), length (L), and head circumference (HC) were measured at birth and 6, 26, 50, and 74 weeks of age. Stored dried blood spot samples from pregnant women randomized to the IP arm were used to measure tenofovir-diphosphate (TFV-DP) levels. Age-stratified mean weight-for-age (WAZ), length-for-age (LAZ), weight-for-length (WLZ), and head circumference-for-age (HCAZ) Results: A total of 455 mother-infant pairs were included in the secondary analysis, 228 in the IP arm and 227 in the DP arm. WAZ, LAZ, WLZ, and HCAZ scores were comparable between infants in the Deferred-PrEP arm and Immediate-PrEP arm. In a mixed-effects linear regression model adjusting for maternal age, body mass index, socioeconomic and newborn characteristics, Conclusion: There was no evidence of an association between growth metrics in the first 18 months of life and

Indexed as

breastfeedingexposuregrowthin-uteropreexposure prophylaxis (PrEP)

Identifiers

PMID39184858
PMCPMC11341386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.